GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test

June 5, 2024

https://www.globenewswire.com/news-release/2024/06/05/2893796/0/en/GeneType-and-Stayhealthy-Announce-Landmark-Distribution-Agreement-for-Revolutionary-Multi-Risk-Test.html

MELBOURNE, Australia, June 05, 2024 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, and Stayhealthy, Inc., a leader in health and wellness technology, are excited to announce a major distribution agreement. This partnership will bring GTG’s innovative Multi-Risk Test to a broader audience in the online pharmacy channel across North America, empowering individuals to take control of their health.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.